<DOC>
	<DOC>NCT00932867</DOC>
	<brief_summary>Surveillance of efficacy and safety of drug PRITOR in patieNts with arterial hypertension, who do not tolerate ACE inhibitoR treatment</brief_summary>
	<brief_title>Surveillance of Efficacy and Safety of Drug PRITOR in patieNts With Arterial Hypertension, Who do Not Tolerate ACE inhibitoR Treatment</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Angiotensin-Converting Enzyme Inhibitors</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<criteria>Patients over 18 years of age Arterial hypertension (SBP &lt; 160 mmHg and DBP &lt; 100 mmHg) Patients, who do not tolerate ACE inhibitors (must be documented in the official ambulant documentation) Inclusion criteria for the control arm (treated by ACEi): Patients over 18 years of age Arterial hypertension (SBP &lt; 160 mmHg and DBP &lt; 100 mmHg) Patients, who tolerate ACEi treatment Cholestasis, severe hepatic insufficiency Allergy to telmisartan Gravidity or lactation Exclusion criteria for the arm of patient treated by ACEi: Cholestasis, severe hepatic insufficiency Allergy to ACEi Gravidity or lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Arterial Hypertension</keyword>
</DOC>